Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.

Antibodies to polymorphic antigens expressed during the parasites erythrocytic stages are important mediators of protective immunity against P. falciparum malaria. Therefore, polymorphic blood stage antigens like MSP3, EBA-175 and GLURP and variant surface antigens PfEMP1 and RIFIN are considered va...

Full description

Bibliographic Details
Main Authors: Louise Turner, Christian W Wang, Thomas Lavstsen, Steven B Mwakalinga, Robert W Sauerwein, Cornelus C Hermsen, Thor G Theander
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3236238?pdf=render
_version_ 1819070460995829760
author Louise Turner
Christian W Wang
Thomas Lavstsen
Steven B Mwakalinga
Robert W Sauerwein
Cornelus C Hermsen
Thor G Theander
author_facet Louise Turner
Christian W Wang
Thomas Lavstsen
Steven B Mwakalinga
Robert W Sauerwein
Cornelus C Hermsen
Thor G Theander
author_sort Louise Turner
collection DOAJ
description Antibodies to polymorphic antigens expressed during the parasites erythrocytic stages are important mediators of protective immunity against P. falciparum malaria. Therefore, polymorphic blood stage antigens like MSP3, EBA-175 and GLURP and variant surface antigens PfEMP1 and RIFIN are considered vaccine candidates. However, to what extent these antibodies to blood stage antigens are acquired during naive individuals' first infections has not been studied in depth. Using plasma samples collected from controlled experimental P. falciparum infections we show that antibodies against variant surface antigens, PfEMP1 and RIFIN as well as MSP3 and GLURP, are acquired during a single short low density P. falciparum infection in non-immune individuals including strain transcendent PfEMP1 immune responses. These data indicate that the immunogenicity of the variant surface antigens is similar to the less diverse merozoite antigens. The acquisition of a broad and strain transcendent repertoire of PfEMP1 antibodies may reflect a parasite strategy of expressing most or all PfEMP1 variants at liver release optimizing the likelihood of survival and establishment of chronic infections in the new host.
first_indexed 2024-12-21T17:06:18Z
format Article
id doaj.art-4ff7e00fb58e43c6852f702c5688dc63
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T17:06:18Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4ff7e00fb58e43c6852f702c5688dc632022-12-21T18:56:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01612e2902510.1371/journal.pone.0029025Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.Louise TurnerChristian W WangThomas LavstsenSteven B MwakalingaRobert W SauerweinCornelus C HermsenThor G TheanderAntibodies to polymorphic antigens expressed during the parasites erythrocytic stages are important mediators of protective immunity against P. falciparum malaria. Therefore, polymorphic blood stage antigens like MSP3, EBA-175 and GLURP and variant surface antigens PfEMP1 and RIFIN are considered vaccine candidates. However, to what extent these antibodies to blood stage antigens are acquired during naive individuals' first infections has not been studied in depth. Using plasma samples collected from controlled experimental P. falciparum infections we show that antibodies against variant surface antigens, PfEMP1 and RIFIN as well as MSP3 and GLURP, are acquired during a single short low density P. falciparum infection in non-immune individuals including strain transcendent PfEMP1 immune responses. These data indicate that the immunogenicity of the variant surface antigens is similar to the less diverse merozoite antigens. The acquisition of a broad and strain transcendent repertoire of PfEMP1 antibodies may reflect a parasite strategy of expressing most or all PfEMP1 variants at liver release optimizing the likelihood of survival and establishment of chronic infections in the new host.http://europepmc.org/articles/PMC3236238?pdf=render
spellingShingle Louise Turner
Christian W Wang
Thomas Lavstsen
Steven B Mwakalinga
Robert W Sauerwein
Cornelus C Hermsen
Thor G Theander
Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
PLoS ONE
title Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
title_full Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
title_fullStr Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
title_full_unstemmed Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
title_short Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
title_sort antibodies against pfemp1 rifin msp3 and glurp are acquired during controlled plasmodium falciparum malaria infections in naive volunteers
url http://europepmc.org/articles/PMC3236238?pdf=render
work_keys_str_mv AT louiseturner antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers
AT christianwwang antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers
AT thomaslavstsen antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers
AT stevenbmwakalinga antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers
AT robertwsauerwein antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers
AT corneluschermsen antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers
AT thorgtheander antibodiesagainstpfemp1rifinmsp3andglurpareacquiredduringcontrolledplasmodiumfalciparummalariainfectionsinnaivevolunteers